However, we will be checking e-mail, of course, and prepare items of interest for our return. Have something interesting for us to see? Send it along. On that note, we look forward to seeing you again and resuming our correspondence. Until then, we leave you with these. Catch a wave, everyone....
Europe Places New Restrictions On Novartis' Prexige (PharmaTimes)
Roche's Avastin Approved For NSCLC In European Union (PharmaTimes)
Merck Lawyer Objects To Petition For New Vioxx Trial (The Madison-St.Clair Record)
ImClones Finance VP Is Resigning (Yahoo/Reuters)
Viagra Boosts Lovey-Dovey Hormone, A Study Says (Yahoo/Reuters)